Developing person-specific signatures of momentary risk for alcohol use

Alcohol use disorder remains a major public health concern, with persistent disparities in treatment outcomes. Traditional interventions often fail to account for the heterogeneity of drinking triggers, limiting their effectiveness. This study aims to develop and evaluate an idiographic, mobile-based clinical tool to identify personalized triggers for alcohol use. Idiographic methods allow for individualized assessments […]

From symptom relief to subtype identification: exploring patterns of cannabis use in PTSD

Post-traumatic stress disorder (PTSD) and substance use often go hand in hand, with many people using substances like cannabis to manage their symptoms. This concept, known as the self-medication hypothesis, suggests that people might use cannabis differently depending on the nature of their symptoms. Symptoms are classically split into domains – hyperarousal, emotional numbing, re-experiencing, […]

Improving risk-stratification of substance-induced psychosis: incorporating stakeholder perspectives and implementing a standardized assessment of risk factors

First-episode substance-induced psychosis (SIP) presents a clinical challenge in which treatment decisions cannot rely on evidence-based guidelines and long-term outcomes are not well understood. Preliminary findings from our retrospective study of psychiatry inpatients at Harborview Medical Center (HMC) suggest that patients with first-episode SIP had similar rehospitalization rates to those with first-episode psychosis (FEP) but […]

Unraveling the genetics of schizophrenia and bipolar disorder with large-language models

Schizophrenia (SCZ) and bipolar disorder (BPD) are among the most heritable psychiatric conditions, yet their genetic foundations remain poorly understood. Historically, unraveling these disorders’ genetic architectures was limited by inadequate technology. However, breakthroughs in next-generation sequencing have recently produced expansive genomic datasets—including those from the Psychiatric Genomics Consortium (PGC)—for SCZ and BD. Simultaneously, genomic foundation […]



AMPERE (Augmented Momentary Personal Ecological Risk Evaluation)

Death by suicide is the 2nd leading cause of death among young adults in the United States. While most patients who die by suicide have had recent contact with their health care providers, the medical delivery system is poorly equipped to address this preventable issue. EMA (ecological momentary assessment) systems show promise as indicators of […]

Evaluating the role of virtual whole health in PC-MHI 

The COVID-19 pandemic facilitated simultaneous paradigm shifts in healthcare delivery: virtual care (telehealth and videoconferencing) and the need for “Whole Person” healthcare that targets mind, body, and spirit, per recent US Surgeon General1 and National Academy of Medicine2 calls-to-action. The pandemic also highlighted treatment delivery inequities involving rural Veterans. The current proposal will address these […]